MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$5,725K
Free Cash flow
-$41,183K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of marketable securit...
    • Stock-based compensation expense
    • Depreciation and amortization
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accrued expenses and other curre...
    • Other non-current assets
    • Others

Cash Flow
2026-03-31
Net loss
-38,262
Depreciation and amortization
1,171
Loss (gain) from disposal of property and equipment
33
Right-of-use asset impairment expense
0
Accretion of discount on marketable securities
296
Stock-based compensation expense
2,587
Non-cash rent expense
879
Change in fair value of contingent consideration and warrant liability
109
Prepaid expenses and other current assets
-3
Other non-current assets
1,686
Accounts payable
484
Lease liabilities
-1,225
Accrued expenses and other current liabilities
-4,766
Net cash used in operating activities
-41,035
Maturities of marketable securities
34,950
Purchases of property and equipment
148
Proceeds from sale of property and equipment
0
Net cash provided by investing activities
34,802
Proceeds from stock options exercised
651
Payment of deferred offering costs
143
Principal payments on finance leases
24
Net cash provided by financing activities
484
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
24
Decrease in cash, cash equivalents and restricted cash
-5,725
Cash, cash equivalents and restricted cash, beginning of period
44,897
Cash, cash equivalents and restricted cash, end of period
39,172
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Maturities of marketablesecurities$34,950K Proceeds from stockoptions exercised$651K Net cash provided byinvesting activities$34,802K Net cash provided byfinancing activities$484K Effect of exchange ratechanges on cash, cash...$24K Canceled cashflow$148K Canceled cashflow$167K Decrease in cash, cashequivalents and restricted...-$5,725K Canceled cashflow$35,310K Stock-based compensationexpense$2,587K Depreciation andamortization$1,171K Non-cash rent expense$879K Accounts payable$484K Change in fair value ofcontingent consideration...$109K Prepaid expenses andother current assets-$3K Purchases of property andequipment$148K Payment of deferredoffering costs$143K Principal payments onfinance leases$24K Net cash used inoperating activities-$41,035K Canceled cashflow$5,233K Net loss-$38,262K Accrued expenses andother current...-$4,766K Other non-currentassets$1,686K Lease liabilities-$1,225K Accretion of discount onmarketable securities$296K Loss (gain) fromdisposal of property and...$33K

Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics, Inc. (ODTX)